Linical
Aaron Sanford is a seasoned professional in clinical operations and study startup, currently serving as the Sr. Director of Study Start Up at Linical since April 2021. Prior to this role, Aaron held multiple leadership positions at PPD from May 2017 to March 2021, including Director of Global Site Intelligence & Activation. Previous experience includes managerial roles at PRA Health Sciences and Accelovance, as well as senior project management positions at PRA International. Aaron holds a Bachelor of Arts degree in Economics from the University of Virginia, obtained between 1999 and 2003.
This person is not in the org chart
This person is not in any offices
Linical
Linical is a global Contract Research Organization (CRO) for full-service drug development, with a proven record of helping biopharmaceutical companies successfully navigate the clinical development journey. Linical is headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. Linical provides a full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases. Combining strong business perspective with clinical and medical expertise, our team goes beyond operational excellence providing flexibility, guidance, and key strategies to successfully overcome drug development and regulatory challenges. We strive to offer professional, high-quality services with the personal attention needed in a constantly evolving pharmaceutical and biotech market. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.